Safety Study of FB102 in Healthy Adults
This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Body weight between 50 and 100 kg (roughly 110–220 lbs)
- BMI (body size ratio) between 18.0 and 32.0
- No serious medical conditions, cancer history, or weakened immune system
- Negative blood tests for hepatitis B, hepatitis C, HIV, and tuberculosis
- Liver function blood tests within normal range
- Women: not pregnant, not breastfeeding, and either unable to have children or willing to use effective birth control for 90 days after the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests a new oral medication, called FB-101, in healthy adult men to see how safe it is and how the body processes it. Participation involves multiple visits and taking the drug in different doses.
This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.